Certara, Inc., a global leader in model-informed drug development, announced it has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics...
Certara, Inc., a global leader in model-informed drug development, unveiled its next-generation CoAuthor regulatory writing software. CoAuthor is an advanced writing platform designed for medical...
Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapies
Certara, Inc., a global leader in biosimulation, announced the...